Neuronopathic forms of Gaucher's disease

Bailliere's Clinical Haematology

Volumn 10, Issue 4, 1997, Pages 711-723

  Erikson, A ^a   Bembi, B ^a   Schiffmann, R ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Administration; Bone marrow transplantation; Brain; Child; Enzymes; Gaucher's disease; Glucosyceramide; Glucosylceramidase; Mutation; Therapeutic use; Therapy; Treatment outcome

Indexed keywords

GLUCOSYLCERAMIDASE;

CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; ENZYME DEFICIENCY; ENZYME REPLACEMENT; GAUCHER DISEASE; GENE MUTATION; GENE THERAPY; HUMAN; NERVE CELL; NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0031436888     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(97)80035-2     Document Type: Article

References (46)

1. Abrahamov A Elstein D Gross-Tsur V Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype [see comments] Lancet 346 1995 1000 1003
2. Ashkenazi A Zaizov R Matoth Y Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease European Journal of Pediatrics 145 1986 138 141
3. Barton NW Brady RO Dambrosia J Replacement therapy for inherited enzyme deficiency—macrophage-targeted glucocerebrosidase for Gaucher's disease [see comments] New England Journal of Medicine 324 1991 1464 1470
4. Bembi B Zanatta M Carrozzi M Enzyme replacement treatment in type 1 and type 3 Gaucher's disease Lancet 344 1994 1679 1682
5. (Abstract) Bembi B Ciana G Zanatta M Cerebrospinal fluid infusion of alglucerase in the treatment of acute neuronopathic Gaucher's disease Pediatric Research 38 1995 425
6. Beutler E Gaucher disease, a paradigm for single gene defects Experientia 51 1995 196 197
7. Beutler E Gaucher disease Advances in Genetics 32 1995 17 49
8. Beutler E Grabowski GA Gaucher disease Scriver CR Beaudet AL Sly WS Valle D The Metabolic and Molecular Bases of Inherited Disease 1995 McGraw-Hill New York 2641 2670
9. Bove KE Daugherty C Grabowski GA Pathological findings in Gaucher disease type 2 patients following enzyme therapy Human Pathology 26 1995 1040 1045
10. Brady RO Gaucher disease Moser HW Handbook of Clinical Neurology 1996 Elsevier Science Amsterdam 123 132
11. Carrozzi M Zanatta M Scabar A Bembi B Enzyme replacement therapy for Gaucher's disease type 1, 2, and 3 Di Donato S Parini R Uziel G Metabolic Encephalopathies 1995 John Libbey Company Ltd. London 123 130
12. Chabas A Cormand B Grinberg D Unusual expression of Gaucher's disease: cardiovascular calcifications in three sibs homozygous for the D409H mutation Journal of Medical Genetics 32 1995 740 742
13. Choy FY Wei C Identification of a new mutation (P178S) in an African-American patient with type 2 Gaucher disease Human Mutation 5 1995 345 347
14. (Berlin) Conradi NG Kalimo H Sourander P Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease Acta Neuropathologica 75 1988 385 390
15. Berlin Conradi NG Sourander P Nilsson O Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies Acta Neuropathologica 65 1984 99 109
16. (Berlin) Conradi N Kyllerman M Mansson JE Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: Neuropathological and neurochemical findings Acta Neuropathologica 82 1991 152 157
17. Correll PH Karlsson S Towards therapy of Gaucher's disease by gene transfer into hematopoietic cells European Journal of Hematology 53 1994 253 264
18. Dreborg S Erikson A Hagberg B Gaucher disease—Norrbottnian type. I. General clinical description European Journal of Pediatrics 133 1980 107 118
19. Dunbar C Kohn D Retroviral mediated transfer of the cDNA for human glucocerebrosidase into hematopoietic stem cells of patients with Gaucher disease. A phase I study Human Gene Therapy 7 1996 231 253
20. Erikson A Gaucher disease—Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment Acta Paediatrica Scandinavica 326 1986 S1 S42
21. Erikson A Astrom M Mansson JE Enzyme infusion therapy of the Norrbottnian (type 3) Gaucher disease Neuropediatrics 26 1995 203 207
22. Frederickson DS Sloan HR Glucosylceramide lipidoses: Gaucher disease Stanbury JB Wyngaarden JB Frederickson DS The Metabolic Basis of Inherited Disease 1972 McGraw-Hill New York 730 759
23. Hillborg PO Morbus Gaucher in Norbotten Nordisk Medicin 61 1959 303 313
24. Hobbs JR Jones KH Shaw PJ Beneficial effect of pre-transplant splenectomy on displacement bone marrow transplantation for Gaucher's syndrome Lancet 1 1987 1111 1115
25. Hollak CE Van Weely S van Oers MH Aerts JM Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease Journal of Clinical Investigation 93 1994 1288 1292
26. Kaye EM Ullman MD Wilson ER Barranger JA Type 2 and Type 3 Gaucher disease: a morphological and biochemical study Annals of Neurology 20 1986 223 230
27. Knudson AG Jr Kaplan WD Genetics of the sphingolipidoses Aronson SM Volk BW Cerebral Sphinolipidoses 1962 Academic Press New York 395 411
28. Krivit W Sung JH Shapiro EG Lockman LA Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases Cell Transplantation 4 1995 385 392
29. Kyllerman M Conradi N Mansson JE Rapidly progressive type III Gaucher disease: deterioration following partial splenectomy Acta Paediatrica Scandinavica 79 1990 448 453
30. Mistry PK Genotype/phenotype correlations in Gaucher's disease [comment] Lancet 346 1995 982 983
31. Neudorder O Giladi N Elstein D Occurrence of Parkinson's syndrome in type I Gaucher disease Quarterly Journal of Medicine 89 1996 691 694
32. Nilsson O Svennerholm L Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease Journal of Neurochemistry 39 1982 709 718
33. Pasmanik-Chor M Laadan S Elroy-Stein O The glucocerebrosidase D409H mutation in Gaucher disease Biochemical and Molecular Medicine 59 1996 125 133
34. Patterson MC Horowitz M Abel RB Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher's disease Neurology 43 1993 1993 1997
35. Ringden O Groth CG Erikson A Ten years' experience of bone marrow transplantation for Gaucher disease Transplantation 59 1995 864 870
36. Rusca CL Sul morbo del Gaucher Hematologica 2 1921 441
37. Schiffmann R Heyes MP Aerts JM Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher disease Annals of Neurology 42 1997 613 621
38. Seeman PJ Finckh U Hoppner J Two new missense mutations in non-Jewish Caucasian family with type 3 Gaucher disease Neurology 46 1996 1102 1107
39. Shiloni E Bitran D Rachmilewitz E Durst AL The role of splenectomy in Gaucher's disease Archives of Surgery 118 1983 929 932
40. Sidransky E Sherer DM Ginns EI Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene Pediatric Research 32 1992 494 498
41. Soffer D Yamanaka T Wenger DA Suzuki K Central nervous system involvement in adultonset Gaucher's disease Acta Neuropathologica (Berlin) 49 1980 1 6
42. Tayebi N Herman J Ginns EI Sidransky E Genotype D399N/R463C in a patient with type 3 Gaucher disease previously assigned genotype N370S/R463C Biochemical and Molecular Medicine 57 1996 149 151
43. Verderese CL Graham OC Holder-McShane CA Gaucher's disease: a pilot study of the symptomatic responses to enzyme replacement therapy Journal of Neuroscience Nursing 25 1993 296 301
44. Winkelman MD Banker BQ Victor M Moser HW Non-infantile neuronopathic Gaucher's disease: a clinicopathologic study Neurology 33 1983 994 1008
45. Xu L Stahl SK Dave HP Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol Experimental Hematology 22 1994 223 230
46. Zimran A Elstein D Schiffmann R Outcome of partial splenectomy for type I Gaucher disease Journal of Pediatrics 126 1995 596 597